例如:"NBL1", "4681", "drought"
收藏
10094 ARPC3

10094

ARPC3

actin related protein 2/3 complex subunit 3

protein-coding

Homo sapiens

基因描述

Type Description
Definition actin related protein 2/3 complex subunit 3

研究结论

Date Results Publications
2017-08-05 11:51:00 Cancer cell motility mediated by the actin-related protein 2/3 complex (Arp2/3) is required for vessel co-option in liver metastases in vivo. 27748747
2016-12-31 10:37:00 genetic association study in population in Canada: Data suggest that an SNP in the promoter region of (CpG-SNP rs3759384 C>T) is associated with metabolic syndrome complicated by severe abdominal obesity and hypertriglyceridemia in the population studied. 27055012
2011-05-07 11:10:00 Endogenous Nogo-B, which may exert its effects through 2/3 and MYL-9, is necessary for the migration and contraction of airway smooth muscle cells. 21251247
2010-01-21 00:00:00 The actin-related protein 3 structures were more visible with anti-p34Arc monoclonal antibody. 15793564

名称对应

Type IDs
Synonymous ARC21, p21-Arc
Gene
UniProtKB-ID: ARPC3_HUMAN
UniprotKB: O15145
UniParc: UPI00001120BE
EMBL: BC067747, CR407667, AF004561, BC078162, AF006086
Ensembl: ENSG00000111229
KO: hsa:10094
Nucleutide sequences
EMBL-CDS: AAB61466.1, AAH78162.1, CAG28595.1, AAH67747.1, AAB64191.1
Ensembl_TRS: ENST00000228825
Protein sequencees
Ensembl_PRO: ENSP00000228825
RefSeq: NP_001265485.1, NP_001274151.1
Others
UniRef100: UniRef100_O15145
UniRef90: UniRef90_O15145
UniRef50: UniRef50_O15145
UniGene: Hs.524741
CCDS: CCDS9146.1

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员